Table 1.
Baseline Characteristics of Patients with HF
| (n=4064) | (n=1294) | (n=5055) | (n=884) | (n=654) | (n=922) | (n=7970) | (n=1060) | (n=2559) | |
|---|---|---|---|---|---|---|---|---|---|
| Age (years) | 59.3 ± 13.3 | 57.4 ± 15.4 | 68.9 ± 15.3 | 65.2 ± 11.2 | 65.9 ± 11.5 | 63.8 ± 11.7 | 63.8 ± 11.4 | 66.1 ± 11.4 | 68.9 ± 9.7 |
| Female (%) | 57.7 | 58.8 | 53.6 | 72.3 | 32.3 | 22.9 | 22.0 | 43.2 | 50.7 |
| LVEF (%) | 55 ± 17 | n/a | 49 ± 17 | 29 ± 14 | 29 ± 8 | 27 ± 8 | 30 ± 6 | 55 ± 9 | 57 ± 11 |
| Diastolic BP (mmHg) | 70 ± 14 | 68 ± 13 | 70 ± 12 | 77 ± 15 | 75 ± 11 | 72 ± 10 | 74 ± 10 | 74 ± 11 | 75 ± 11 |
| Creatinine (mg/dl) | 1.0 [0.8–1.5] | 1.2 [0.8–1.8] | 1.1 [0.9–1.6] | 1.1 [0.9–1.4] | 1.1 [0.9–1.4] | 1.1 [0.9–1.3] | 1.1 [0.9–1.3] | 1.0 [0.8–1.3] | 1.1 [0.9–1.3] |
| Blood urea nitrogen (mg/dl) | 19.2 [13.2–29.0] | 21.6 [14.5–35.8] | 21.6 [15.2–31.6] | 22.0 [14.6–34.2] | 21.0 [16.0–29.4] | 21.0 [16.0–27.0] | 19.0 [15.0–24.0] | 20.0 [15.7–26.6] | 19.0 [14.8–25.2] |
| Albumin (g/dl) | 3.6 ± 0.7 | 3.2 ± 0.7 | 3.7 ± 0.6 | 3.2 ± 0.9 | - | - | 4.3 ± 0.3 | - | 4.1 ± 0.5 |
| White blood cell count (x103/l) | 8.4 [6.2–11.5] | 8.0 [6.1–11.0] | 7.2 [5.6–9.1] | 7.9 [6.4–9.6] | 7.0 [5.9–8.4] | 7.1 [5.8–8.6] | 6.7 [5.6–8.1] | 7.0 [5.8–8.4] | 6.7 [5.6–8.0] |
| Hemoglobin (g/dl) | 11.3 ± 2.6 | 11.6 ± 2.4 | 11.7 ± 2.1 | 13.3 ± 2.0 | 13.5 ± 1.7 | 13.8 ± 1.6 | 13.9 ± 1.6 | 13.4 ± 1.6 | 13.1 ± 1.7 |
| RDW (%) | 14.8 [13.7–16.5] | - | 15.2 [14.0–16.8] | - | 14.5 [13.6–15.7] | 14.3 [13.5–15.3] | - | 14.3 [13.4–15.4] | - |
| Platelets (x103/l) | 204 [143–272] | 194 [135–258] | 223 [173–285] | 221 [181–265] | 223 [184–266] | 217 [180–259] | 193 [161–230] | 227 [189–274] | 222 [190–260] |
| MARKER-HF | −0.14 ± 0.20 | −0.06 ± 0.19 | −0.19 ± 0.16 | −0.17 ± 0.17 | −0.25 ± 0.08 | −0.24 ± 0.08 | −0.33 ± 0.07 | −0.26 ± 0.08 | −0.29 ± 0.11 |
Values reported as: Mean ± SD for normally distributed variables or as median and [IQR] for the others.